Filter by type Show all Pages Solutions Expertise Reports News Webinars Events Locations FAQs Case Studies Whitepapers Filter By Any Pages Solutions Expertise Reports News Webinars Events Locations FAQs Case Studies Whitepapers December 10, 2019 News Novotech CRO sees changing landscape in Hemato-Oncology at ASH 2019 Novotech, the Asia-Pacific CRO, attends the American Society of Hematology conference in Orla Read more October 12, 2022 Report Paroxysmal nocturnal hemoglobinuria (PNH) According to estimates, 1-2 cases per million people develop PNH annually in Western nations, while the rate is roughly 10 per million each year in Asia, with China and India showing the highest in Download May 26, 2022 Report Follicular lymphoma - Asia pacific - clinical Trial landscape Owing to its large population base, Asia may account for over 40% of the estimated global incidence of Follicular Lymphoma, with China, Japan and India collectively contributing to over a quarter o Download September 17, 2021 Report Clinical trial landscape of diabetes (type 2) in asia-pacific Diabetes, which is endemic in most Western countries, is now seeing a surge in developing nations across Asia due to aging, urbanization, and changing dietary habits. Download August 20, 2021 Report Clinical trial landscape of t-cell lymphomas in asia-pacific T-cell lymphomas (TCLs) are types of non-Hodgkin’s lymphoma (NHL) that affect T lymphocytes. Download August 22, 2022 Report Diffuse large b-cell Lymphoma – Asia Pacific – Clinical trial landscape Asia accounted for nearly 70% of the global incidence of DLBCL in 2020, with Mainland China, India, and Japan contributing to a third of all DLBCL cases worldwide. Download October 14, 2021 Report Clinical trial landscape Of cll in asia-pacific CLL is one of the most common forms of leukaemia, with the Asia Pacific region showing increasing incidence. China and South Korea are among the Asian locations showing the greatest incidence. Download August 27, 2021 Report Clinical trial landscape of B-cell lymphoma in asia-pacific Diffuse Large B-Cell Lymphoma (DLBCL) is the most common and the most aggressive subtype constituting nearly 70% of B-Cell Lymphomas in Asia. Download July 21, 2022 Webinar Evolution of cell & gene therapy in China: the case for universal CAR-T Arsalan: Hi, everyone, Arsalan Arif here with Endpoints News, and thanks for joining us to Watch Solution Laboratory Services May 26, 2022 News Novotech Acquires US CRO - Expands Global Expertise Singapore and Charleston, SC - Novotech, the leading Asia-Pacific Read more May 30, 2022 Webinar Development and Regulatory Strategy for US and China Speakers and Panelists Bio： Watch September 24, 2021 News Regional Lead CRA THE NEXT STEP IN YOUR CLINICAL RESEARCH CAREER If you have passion for the clinical ope Read more Load More
